Comprehensive Nursing Pharmacology Q 145
Antitubercular therapy may be determined ineffective when:
A. Sputums are negative
B. Symptoms resolve
C. Hepatitis results
D. Drug-resistant bacteria emerge
Correct Answer: D. Drug-resistant bacteria emerge.
The emergence of drug-resistant bacteria indicates that antitubercular therapy is ineffective because the drug(s) are no longer ending bacterial multiplication. A feared complication of tuberculosis therapy is multi-drug-resistant tuberculosis(MDR-TB). MDR-TB is distinguished from its resistance to first-line medications isoniazid and rifampin. Therapy for MDR-TB is steadily advancing, and suggestions are continually changing.
Option A: A negative sputum is the desired effect. Second-line drugs that are in common use for MDR-TB are kanamycin, capreomycin, and amikacin via injections.[4] Fluoroquinolones such as levofloxacin, moxifloxacin, and gatifloxacin and are also amongst the common second-line agents used when drug resistance develops to the first-line agents.
Option B: Resolved symptoms is the desired effect of the therapy. Drugs that have recently received FDA approval for the multi-drug resistant TB are pretomanid, used in sequence with bedaquiline, and linezolid.
Option C: Liver function tests should be monitored routinely as rifampin, isoniazid, pyrazinamide, and ethambutol all may exert hepatotoxic effects. All first-line antitubercular medications, rifampin, isoniazid, pyrazinamide, and ethambutol can exert hepatotoxic effects. A continual rise in liver functions test should prompt discontinuation of treatment.